» Articles » PMID: 6450260

Regulation of Murine Macrophage Ia-antigen Expression by Products of Activated Spleen Cells

Overview
Journal J Exp Med
Date 1980 Dec 1
PMID 6450260
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

This investigation examined the effects of mediators derived form activated spleen cells on macrophage Ia-antigen expression and function. Incubation of adherent thioglycollate-induced murine peritoneal macrophages(> 90% Ia-) with concanavalin A (Con A)-stimulated spleen cell supernate (Con A sup) resulted in a dose-dependent increase in the percentage of Ia-containing (Ia+) phagocytic cells, as detected by antiserum-and-complement-mediated cytotoxicity. The Ia-antigen expression of macrophages incubated with unstimulated spleen cell supernate supplemented with Con A (Control sup) declined. Pretreatment of the macrophages with anti-Ia and complement before addition of the Con A sup did not inhibit subsequent Ia-antigen expression, suggesting that Ia- macropohages were converted to Ia+ cells. These findings were not a result of adsorption of soluble Ia-antigen from the Con A sup, because Ia-antigen expression was detected by an antiserum specific for the haplotype of the macrophages but not that of the allogeneic spleen cells from which the supernate was prepared. Con A sup-cultured macrophages also stimulated the proliferation of allogeneic spleen cells significantly better than Control sup-cultured macrophages in the mixed leukocyte reaction (MLR). Pretreatment of Con A sup-cultured macrophages with anti-Ia and complement before addition of splenic responder cells abrogated their stimulatory capacity, indicating the Ia dependence of the MLR. We hypothesize that regulatory lymphokine(s) can induce both the expression of the Ia+ phenotype by macrophages and the functional capability to stimulate the MLR, and that macrophages lose these capabilities in the absence of such mediator(s).

Citing Articles

Protective role of spleen-derived macrophages in lung inflammation, injury, and fibrosis induced by nitrogen mustard.

Venosa A, Malaviya R, Gow A, Hall L, Laskin J, Laskin D Am J Physiol Lung Cell Mol Physiol. 2015; 309(12):L1487-98.

PMID: 26475734 PMC: 4683320. DOI: 10.1152/ajplung.00276.2015.


Graft-versus-host disease and the Th1/Th2 paradigm.

Krenger W, Ferrara J Immunol Res. 1996; 15(1):50-73.

PMID: 8739565 DOI: 10.1007/BF02918284.


Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis.

Klareskog L, Forsum U, Scheynius A, Kabelitz D, Wigzell H Proc Natl Acad Sci U S A. 1982; 79(11):3632-6.

PMID: 6980416 PMC: 346477. DOI: 10.1073/pnas.79.11.3632.


Down-regulation of mannosyl receptor-mediated endocytosis and antigen F4/80 in bacillus Calmette-Guérin-activated mouse macrophages. Role of T lymphocytes and lymphokines.

Ezekowitz R, Gordon S J Exp Med. 1982; 155(6):1623-37.

PMID: 6978922 PMC: 2186710. DOI: 10.1084/jem.155.6.1623.


Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity.

Steeg P, Moore R, Johnson H, Oppenheim J J Exp Med. 1982; 156(6):1780-93.

PMID: 6816896 PMC: 2186868. DOI: 10.1084/jem.156.6.1780.


References
1.
Bradley T, Metcalf D . The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci. 1966; 44(3):287-99. DOI: 10.1038/icb.1966.28. View

2.
Pike B, Robinson W . Human bone marrow colony growth in agar-gel. J Cell Physiol. 1970; 76(1):77-84. DOI: 10.1002/jcp.1040760111. View

3.
Schwartz R, Fathman C, Sachs D . Inhibition of stimulation in murine mixed lymphocyte cultures with an alloantiserum directed against a shared Ia determinant. J Immunol. 1976; 116(4):929-35. View

4.
Greineder D, Shevach E, Rosenthal A . Macrophage-lymphocyte interaction. III. Site of alloantiserum inhibition of T lymphocyte proliferation induced by allogeneic or aldehyde-bearing cells. J Immunol. 1976; 117(4):1261-6. View

5.
Watson J . Differentiation of B lymphocytes in C3H/HeJ mice: the induction of Ia antigens by lipopolysaccharide. J Immunol. 1977; 118(3):1103-8. View